English
Arabic
Armenian
Chinese (Simplified)
Chinese (Traditional)
Czech
Dutch
Tagalog
French
Frisian
German
Irish
Italian
Korean
Farsi
Polish
Portuguese
Romanian
Russian
Spanish
Swedish
Ukrainian
VietnameseVivera BioSciences is focused on developing a selection of non-addictive drugs for indications including cardiovascular conditions and central nervous system and fluency disorders. The division pipeline centers around the utilization of TABMELT, the patient-centric drug delivery alternative for oral and injectable medications. TABMELT is a sublingual drug delivery system that allows patients to take medicines in seconds by dissolving them under the tongue.
Visit vivera.bio to learn more.
